-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

114.O3.6 114. Hemoglobinopathies, Excluding Thalassemia—Clinical:Novel Treatments for Sickle Cell Disease

Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Adult, Biological, sickle cell disease, Diseases, Non-Biological, thalassemia, Therapies, cellular interactions, Pediatric, red blood cells, Biological Processes, Hemoglobinopathies, gene therapy, Young Adult, Cell Lineage, opioids, Study Population, Clinically relevant, pharmacology, inflammation, molecular interactions
Monday, December 7, 2020: 1:30 PM-3:00 PM
Moderators:
Parul Rai, MD, MBBS, St Jude Children's Research Hospital and Kerry A Morrone, MD, Children's Hospital At Montefiore
Disclosures:
No relevant conflicts of interest to declare.
1:30 PM

Alexis A. Thompson, MD1,2, Mark C. Walters, MD3, Markus Y Mapara, MD, PhD4, Janet L. Kwiatkowski, MD, MSCE5,6, Lakshmanan Krishnamurti, MD7, Banu Aygun, MD8,9, Kimberly A. Kasow, DO10*, Stacey Rifkin-Zenenberg, DO11, Manfred Schmidt, PhD12*, Jay DelCarpini13*, Francis J. Pierciey Jr.13*, Alexandra L. Miller13*, Meghan E. Gallagher, MSc13*, Ren Chen13*, Sunita Goyal, MD13*, Julie Kanter, MD14 and John F. Tisdale, MD15,16

1Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL
2Northwestern University Feinberg School of Medicine, Chicago, IL
3UCSF Benioff Children's Hospital Oakland, Oakland, CA
4Columbia University Medical Center, New York, NY
5University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
6The Children's Hospital of Philadelphia, Philadelphia, PA
7Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta, Emory University, Atlanta, GA
8Cohen Children’s Medical Center, New Hyde Park, NY
9Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY
10University of North Carolina At Chapel Hill, Chapel Hill, NC
11Joseph M. Sanzari Children’s Hospital, Hackensack University Medical Center, Livingston, NJ
12GeneWerk GmbH, Heidelberg, Germany
13bluebird bio, Inc., Cambridge, MA
14University of Alabama at Birmingham, Birmingham, AL
15Clinical and Molecular Therapeutics Branch, NHLBI / NIDDK, NIH, Bethesda, MD
16National Institutes of Health, Bethesda, MD

1:45 PM

Carlton D. Dampier, MD1, Marilyn J. Telen, MD2, Ted Wun, MD3, Wally R Smith, MD4, R. Clark Brown, MD, PhD5, Payal Desai, MD6, Fuad A El Rassi, MD7, Julie Kanter, MD8, Beng R. Fuh, MD9, Yves D. Pastore, MD10, Jennifer A. Rothman, MD11, James G. Taylor, MD12, David Readett, BM, BS, MRCP13*, Jay N Lozier, MD, PhD14, John L. Magnani, PhD15, Helen M Thackray, MD16 and Kathryn L. Hassell, MD17

1Emory University, Atlanta, GA
2Duke University Medical Center, Duke Comprehensive Sickle Cell Center, Durham, NC
3Division of Hematology Oncology, UC Davis School of Medicine, Sacramento, CA
4Virginia Commonwealth University, Richmond, VA
5Department of Pediatrics, Aflac Cancer & Blood Disorders Center of Children’s Healthcare of Atlanta and the Department of Pediatrics, Emory University, Atlanta, GA
6The Ohio State University, Columbus, OH
7Department of Hematology and Medical Oncology, Winship Cancer Institute, Atlanta, GA
8University of Alabama, Director of the UAB Adult Sickle Cell Clinic Associate Professor in the Division of Hematology and Oncology, Birmingham, AL
9East Carolina University Comprehensive Sickle Cell Center, Greenville, NC
10CHU Sainte-Justine, University of Montreal, Montreal, QC, Canada
11Duke University Medical Center, Durham, NC
12Center for Sickle Cell Disease, Howard University, Washington, DC
13Pfizer Inc., Groton, CT
14Jay Lozier Consulting, LLC, Olney, MD
15Glycomimetics, Inc., Rockville, MD
16GlycoMimetics Inc., Rockville, MD
17University of Colorado Denver HSC, Aurora, CO

2:00 PM

R. Clark Brown, MD, PhD1, Kimberly Cruz, MD, MS2*, Theodosia A. Kalfa, MD, PhD3, Frans A. Kuypers, PhD4*, Santosh L. Saraf, MD5, Jeremie H. Estepp, MD6, Luke R. Smart, MD3, Punam Malik, MD7, Mark Lerman, MD8*, Renae Mayer, MD9*, Maria D. Ribadeneira, PhD10*, Sanjeev Forsyth, MS10*, Patricia Schroeder, PhD10*, Eric Wu, PhD10*, Patrick Kelly, MD10 and Marilyn J. Telen, MD11

1Department of Pediatrics, Aflac Cancer & Blood Disorders Center of Children’s Healthcare of Atlanta and the Department of Pediatrics, Emory University, Atlanta, GA
2Advanced Pharma, Miami, FL
3Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
4Children's Hospital Oakland Research Institute, Oakland, CA
5Department of Medicine, University of Illinois at Chicago, Chicago, IL
6Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN
7Cincinnati Children's Hospital Medical Center, Cincinnati, OH
8Atlanta Center for Medical Research, Atlanta, GA
9Lynn Institute, Tulsa, OK
10Forma Therapeutics, Inc., Watertown, MA
11Duke Univ. Med. Ctr., Durham, NC

2:15 PM

Michael Grimley, MD1, Monika Asnani, PhD2*, Archana Shrestha3*, Sydney Felker4,5*, Carolyn Lutzko, PhD6*, Paritha I. Arumugam, PhD4*, Scott Witting, PhD7*, Jennifer Knight-Madden, MBBS, PhD8*, Omar Niss, MD9, Charles T. Quinn, MD6, Chris Lo, BS10*, Courtney R Little, BSN11*, Joseph W. McIntosh, MD10* and Punam Malik, MD4

1Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
2Carribean Health Research Institute, Kingston, Jamaica
3Cincinnati Children's Hospital and Medical Center, Cincinnati, OH
4Cincinnati Children's Hospital Medical Center, Cincinnati, OH
5Immunology Graduate Program, University of Cincinnati College of Medicine, Cincinnati, OH
6Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
7Cincinnati Children's Hospital, Cincinnati, OH
8Caribbean Institute for Health Research, The University of the West Indies, Kingston, Jamaica
9Division of Hematology, Cincinnati Children's Hospital, Cincinnati, OH
10Aruvant Sciences, New York, NY
11Aruvant Sciences, Felicity, OH

2:30 PM

Julia Z. Xu, MD, MS1, Anna Conrey, NP1*, Ingrid Frey, RN, BSN, MS1*, James Nichols, RN1*, Laurel A Menapace, MD1, Laxminath Tumburu, PhD1*, Timothy Lequang, MSc1*, Quan Li, PhD2*, Emily Dunkelberger, PhD2*, Eric Henry, PhD2*, Troy Cellmer, PhD2*, Varsha Iyer3*, Heidi Mangus, BS3*, Charles Kung, PhD3*, Lenny Dang, PhD3*, Penelope A. Kosinski, MS3*, Peter Hawkins, PhD3*, Neal Jeffries, PhD4*, William Eaton, MD2 and Swee Lay Thein, DSc, FRCP, MBBS, MRCP1

1Sickle Cell Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
2National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD
3Agios Pharmaceuticals, Inc., Cambridge, MA
4Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD

*signifies non-member of ASH